As of Apr 24
| +0.355 / +1.30%|
The 5 analysts offering 12-month price forecasts for Depomed Inc have a median target of 26.00, with a high estimate of 30.00 and a low estimate of 20.00. The median estimate represents a -5.95% decrease from the last price of 27.65.
The current consensus among 5 polled investment analysts is to Buy stock in Depomed Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.